This episode explores the critical strategic decision for medical device manufacturers in Saudi Arabia: moving from a distributor-based Local Authorized Representative (LAR) to an independent one. We delve into the significant risks of tying your SFDA product registrations to a commercial partner and outline the clear benefits and straightforward process for making the switch. Learn how to take control of your market access, enhance your strategic flexibility, and secure your business in the Kingdom. • What are the hidden risks of appointing your Saudi distributor as your regulatory representative? • How can a distributor-LAR relationship hold your market access hostage? • What are the strategic advantages of using an independent, third-party LAR? • Is it difficult to switch from a distributor to an independent LAR in Saudi Arabia? • Do you need your current distributor’s permission to make the change? • Will you lose your existing product registrations (MDMA) if you switch representatives? • What does the SFDA require for a smooth transfer process? • Why is this topic more important than ever for low-risk devices since September 2022? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.